Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ApoGen Biotechnologies

ApoGen Biotechnologies
2014 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Series A LATEST DEAL TYPE
$11M LATEST DEAL AMOUNT
10 INVESTORS
Description

Operator of a pharmaceutical and biotechnology company intended to focus on the development of a new class of therapeutics targeting drivers of cancer genomic mutation. The company's pharmaceutical and biotechnology process offers therapies that target key drivers of ongoing DNA mutation and tumor evolution, enabling doctors to break drug resistance in cancer treatment.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Primary Office
  • 1616 Eastlake Ave East
  • Suite 200
  • Seattle, WA 98102
  • United States

+1 (206) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore ApoGen Biotechnologies’s full profile, request a free trial.

ApoGen Biotechnologies Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 23-Aug-2018 $11M 0000 000.00 Completed Startup
1. Seed Round Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

ApoGen Biotechnologies Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 0,000,000 00.000000 00 00 00 00 00.000
To view this company’s complete Cap Table, request access »

ApoGen Biotechnologies Competitors (34)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Gyroscope Therapeutics Venture Capital-Backed Stevenage, United Kingdom 000.00 00000000000 000.00
000000 00000000000 Corporation Plymouth Meeting, PA 000 000.00 0000000000 000.00
000000000000 Venture Capital-Backed Houston, TX 000.00 00000000000 000.00
000000000 00000000 Formerly VC-backed Cambridge, MA 000 00000 00000000 00000
0000000 0000000000 Formerly VC-backed Dallas, TX 00 00000 000000&0 00000
To view this company’s complete list of competitors, request access »

ApoGen Biotechnologies Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
AbbVie Ventures Corporate Venture Capital Minority 000 0000 000000 0
Accelerator Life Science Partners Venture Capital Minority 000 0000 000000 0
Alexandria Venture Investments Corporate Venture Capital Minority 000 0000 000000 0
ARCH Venture Partners Venture Capital Minority 000 0000 000000 0
Eli Lilly Corporation Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

ApoGen Biotechnologies Executive Team (4)

Name Title Board
Seat
Contact
Info
Daniel Harki Ph.D Co-Founder
Reuben Harris Ph.D Co-Founder
Thong Le Chief Executive Officer & Board Member
John Santini Ph.D Co-Founder & Board Member

ApoGen Biotechnologies Board Members (7)

Name Representing Role Since Contact
Info
Asish Xavier ApoGen Biotechnologies Board Member 000 0000
James Sullivan ApoGen Biotechnologies Board Member 000 0000
Joel Marcus ApoGen Biotechnologies Board Member 000 0000
John Santini Ph.D Self Co-Founder & Board Member 000 0000
Johnston Erwin ApoGen Biotechnologies Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »